Related Experiment Video
Updated: Aug 26, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Guideline Adherence and Practice Patterns in the Management of Medullary Thyroid Cancer
Nicholas A Frisco1, Alexander H Gunn1, Frances Wang2
1Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Introduction:
Little is known about nationwide practice patterns for the management medullary thyroid cancer (MTC) in relation to the 2015 American Thyroid Association guidelines and their impact on survival.
Methods:
Using the Surveillance, Epidemiology, and End Results Program database (2000-2018), MTC treatment patterns were evaluated in terms of adherence to the 2015 American Thyroid Association guidelines across three time periods (2000-2009, 2010-2015, and 2016-2018). Outcomes of interest were guideline concordance, treatment utilization trends, disease-specific survival (DSS), and overall survival (OS).
Results:
A total of 3332 patients with MTC were identified. Of which, 53.8%, 33.2%, and 11.4% of patients had localized, regional, and distant disease, respectively. In patients with locoregional disease, the rate of guideline-concordant surgery improved over time from 63.0% in 2000-2009 to 76.0% in 2016-2018 (P < 0.001). Guideline-concordant care was associated with increased OS (HR = 1.85, 95% CI: 1.42-2.43, P < 0.001) in patients with localized disease and increased DSS (HR = 1.65, 95% CI: 1.01-2.54, P < 0.001) and OS (HR = 1.89, 95% CI: 1.35-2.58, P < 0.001) in patients with regional disease. The median OS and DSS in patients with distant disease were 31 and 55 mo, respectively, and the rate of chemotherapy use rose from 21.6% to 39.2% (P = 0.003).
Conclusions:
The rate of guideline-concordant surgery for locoregional MTC increased after guideline publication in 2015, with an observed prolongment in OS and DSS. Chemotherapy use among patients with distant disease has increased over time, but their prognosis remains variable.
Insights
Adherence to 2015 American Thyroid Association guidelines for medullary thyroid cancer (MTC) management improved post-2015. Guideline-concordant care is linked to better survival outcomes for localized and regional MTC patients.
Area of Science:
- Endocrinology
- Oncology
- Surgical Oncology
Background:
- Nationwide practice patterns for medullary thyroid cancer (MTC) management and their impact on survival in relation to the 2015 American Thyroid Association (ATA) guidelines are not well understood.
- Evaluating treatment trends and outcomes is crucial for optimizing patient care.
Purpose of the Study:
- To assess nationwide practice patterns for medullary thyroid cancer (MTC) management.
- To evaluate adherence to the 2015 American Thyroid Association (ATA) guidelines.
- To determine the impact of guideline-concordant care on survival outcomes.
Main Methods:
- Utilized the Surveillance, Epidemiology, and End Results (SEER) Program database (2000-2018) to identify 3332 MTC patients.
- Analyzed treatment patterns across three time periods: 2000-2009, 2010-2015, and 2016-2018.
- Assessed guideline concordance, treatment utilization, disease-specific survival (DSS), and overall survival (OS).
Main Results:
- Guideline-concordant surgery rates for locoregional MTC increased from 63.0% (2000-2009) to 76.0% (2016-2018).
- Guideline-concordant care was associated with improved overall survival (OS) in localized disease and both disease-specific survival (DSS) and OS in regional disease.
- For distant MTC, median OS was 31 months and median DSS was 55 months, with a rise in chemotherapy use from 21.6% to 39.2%.
Conclusions:
- The rate of guideline-concordant surgery for locoregional MTC has increased since the 2015 ATA guideline publication.
- Guideline-concordant care is associated with prolonged OS and DSS.
- While chemotherapy use has increased for distant MTC, prognosis remains variable.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Myocarditis IV: Nursing Management

